Lynn Csontos, Vice President of Regulatory Affairs at STEMCELL Technologies, has worked in the biotechnology industry for over 25 years. Her background is primarily with small molecule API and drug products, and she uses that knowledge to navigate the regulatory landscape currently being defined for cellular, gene, and tissue engineered therapies.